In this article, we describe a pharmacogenetics solution that enables to selectively and reversibly inactivate LC neurons making use of Designer Receptors Solely Activated by Designer Medication (DREADD). We show the expression in the hM4Di DREADD is often limited to noradrenergic LC neurons Which the level of LC inhibition may https://joycer949qkd9.madmouseblog.com/profile